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Objectives: To assess the impact of anaemia on incidence of post-stroke dementia. 
Patients and Methods: We used data from a UK regional stroke register. To be eligible, 
patient must have survived to discharge and had anaemia by WHO criteria.  Dementia status 
and other prevalent co-morbidities were assessed using ICD-10 codes. Patients were followed 
till May 2015 (mean follow-up 3.7 years, total person years = 27,769). Hazard Ratio for 
incident dementia was calculated using Cox-proportional hazards model controlling for 
potential confounders. Fine and Gray model was additionally constructed using mortality as 
the competing risk.  
Results: A total of 7,454 stroke patients were included with mean age (SD) of 75.9(12.3) 
years (50.2% men). Those with anaemia were older, has higher disability and co-morbidity 
burden prior to stroke. We observed a large amount of variation in the dementia incidence 
rates over time and that the hazard ratio increased every year.  The significant association 
between anaemia and dementia incidence was lost after controlling for pre-stroke Modified 
Rankin score (HR1.17(0.97,1.40)). With every 20g/dL increase in Hb was associated with a 
significant reduction in the risk of dementia after adjustment for age, sex, stroke factors and 
disability but lost significance after adjustment for vascular risk factors. Competing risk 
analyses showed similar results.  
Conclusion: Whilst we found no evidence of anaemia as a risk factor for post-stroke 






Anaemia is common in patients with acute stroke. The prevalence figure of up to 30% has 
been reported in hospital-based studies [1][2]. Our recent work demonstrated that 25% of 
stroke patients were  anaemic at the time of hospital admission [3]. The aetiology of dementia 
after a stroke or transient ischaemic attack (TIA) has been highlighted in research [4]. The 
link between anaemia and cognition has also grown a considerable interest over the last few 
decades [5][6][7]. Systematic reviews and meta-analyses published in this area suggest 
potential link between anaemia and cognitive decline or dementia in older aged cohorts 
[8][9][10].   
 
With post-stroke dementia being a significant issue, there is now a pressing need for greater 
understanding of risk factors for dementia in this patient group. One potential risk factor may 
be anaemia as suggested in general populations [9][10]. The proposed pathophysiology 
mechanisms include direct effect of chronic cerebral hypoxia., as a marker of diseases and 
processes such as ischemic and lower erythropoietin levels increasing the risk of neuronal 
degeneration. Others include iron dysregulation associated with increased brain oxidative 
stress, and chronic cerebral hypoperfusion in the prefrontal cortex or inflammatory 
neurodegenerative processes. It was also suggested that anaemia may cause the progression 
of white matter disease through low physical function with heightened vascular disease risk 
[9]. Despite different pathological mechanisms, post stroke dementia occurs as the result of 
vascular dementia or mixed (Alzheimer’s and vascular dementia) and thus regarded as a 




However, few studies have examined this link in stroke patients. Given that stroke has high 
mortality in the first year and the fact that anaemia contribute this mortality risk [3], it is 
unclear whether stroke survivors who were anaemic would have either increased or decreased 
risk of post-stroke dementia.  
 
Patients and Methods 
 
The study population consisted of 7,454 stroke patients consecutively admitted between 
January 2003 – May 2015 to Norfolk and Norwich University Hospital, a regional tertiary 
centre in East Anglia, UK, with a catchment population of approximately 750,000. Ethical 
approval was obtained from the Newcastle and Tyneside National Health Service (NHS) 
Research Ethics Committee (12/NE/0170) and the study protocol was approved by the 
Steering Committee of the Register.  Of 11,727 entries, 991 repeated entries (with second or 
third stroke recorded in the register were excluded. After further exclusion of 2,404 who died 
as in-patient, there were a total of 8,332 who were discharged from hospital for the first 
recorded stroke in the register, 379 had previous history of dementia prior to stroke and 
therefore excluded. 499 participants did not have haemoglobin values and had missing data 
for other co-variates and thus further excluded. 
 
The data collection methods for this prospective hospital-based register have been previously 
reported [11]. Briefly, the data were obtained from paper and electronic records, reviewed 
and then entered onto the register database by the hospital stroke data team and vetted by 
clinical team members for accuracy. For each patient admitted, the pre-stroke modified 
Rankin score (mRS), as modified by UK-TIA investigators [12], was ascertained from 
nursing and medical records by stroke specialist nurses. At discharge, the dead or alive status 
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was recorded to capture in-hospital mortality. Follow-up for mortality was obtained by 
electronic record linkage with Office of National Statistics data through hospital episodes in 
May 2015.  
 
To be eligible in the current study, patients could not have history of dementia (any type) 
prior to stroke and they must have survived to hospital discharge. Haemoglobin level 
obtained closed to discharge was used to determine the Hb or anaemia status. Only confirmed 
cases of stroke were included. Stroke was diagnosed using evidence from clinical features 
and neuroimaging (typically CT and in some cases MRI). Anaemia was defined according to 
the WHO criteria of Hb <12.0 g/dL in females and <13.0 g/dL in males and elevated 
haemoglobin was defined as >15.5g/dL in females and >17.0g/dL in males [13].   
 
The variables included were age, sex, stroke sub-type (ischaemic/haemorrhagic), pre-stroke 
disability depicted by modified Rankin score (mRS), Oxfordshire Community Stroke Project 
(OCSP) classification (Total Anterior Circulation Stroke, Partial Anterior Circulation Stroke,  
Posterior Circulation Stroke, Lacunar Stroke), haemoglobin levels at discharge, co-
morbidities (coronary heart disease including myocardial infarction, congestive heart failure 
(CHF), atrial fibrillation, hypertension, hyperlipidaemia, previous Stroke, diabetes mellitus, 
peripheral vascular disease, chronic obstructive pulmonary disease (COPD), chronic kidney 
disease (CKD), and malignancy).  
 
Dementia incidence was captured through UK NHS record linkage system via the patient 
administrative system (PAS) which records both secondary care and primary care based 
diagnosis of dementia in the NHS setting. International Classification of Disease (ICD) 10 
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codes F00, F01, F02 and F051 were used to capture both prevalent and incident dementia. 
Statistical analysis 
Characteristics of the individuals with and without anaemia were summarized using 
descriptive statistics and compared using a chi-squared test for categorical variables and a t-
test for continuous variables. Annual incidence rates of stroke were calculated for each 
calendar year of follow-up stratified by year of study entry, excluding individuals who died in 
the year from the denominator.  
 
The association between anaemia and dementia incidence was described using Kaplan-Meier 
plots and estimated using a cox proportional hazards model. This was done for six separate 
models A-F using hierarchical adjustments. The association was adjusted for age and sex in 
model A; model B adjusted additionally for stroke characteristics, model C additionally 
adjusted for pre-stroke modified Rankin score, model D additionally adjusted for key risk 
factors for dementia namely atrial fibrillation, coronary heart disease, previous stroke or TIA, 
peripheral vascular disease and history of hypertension. Model E additionally adjusted for 
other major co-morbidities which included COPD, CKD, CHF, hyperlipidaemia, diabetes, 
and malignancy. Model F additionally adjusted for year of stroke to account for the 
possibility that dementia diagnoses changed of the course of the follow-up period. The 
association between haemoglobin (Hb) and stroke incidence was assessed in a similar fashion 
using the same models. No major departures from the model assumptions were observed. As 
anaemia is also associated with death a competing risk model (Fine and Gray) was fitted 








A total of 7,454 stroke patients were included in the current report; their mean age (SD) was 
75.9 (12.3) years and there were 3,742 (50.2%) men. (mean follow up = 3.7 years, median 
follow up = 2.9 years, total person years = 27,769 years). Table 1 shows the sample 
characteristic comparison between those with and without anaemia at the time of discharge 
by sex specific analysis. It demonstrates that most factors considered are significantly 
different between individuals with anaemia and those without; those with anaemia tended to 
be older and significantly more likely to be more disabled prior to stroke with higher burden 
of co-morbidities.  
 
Figure 1 shows the Kaplan Meier Curve showing linear trends in development of dementia in 
patients without (top line) and with (bottom line) anaemia. Supplementary Table 1 shows 
that there is a large amount of variation in the incidence rates over time. Kaplan-Meier plot 
with each year being a separate line demonstrate clearly that the hazard ratio has generally 
increased every year (apart from 2015 which does not have full year of follow-up) (see 
Figure 2).  
 
Table 2 shows the estimated hazards ratios and corresponding 95% confidence intervals. 
This shows a significant association between anaemia and dementia incidence, but this loses 
significance on adjusted for pre-stroke mRS. A similar pattern is observed when Hb was 
entered into model as a linear variable (with every 20g/dL increase) with a significant 
reduction in the risk of dementia until adjustment for key risk factors of dementia. Once 
competing risks are accounted for, this association loses significant in all but model A. This 
is suggestive that the association observed before adjustment is due to the imbalance in the 
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characteristics at baseline between the two groups and that once the competing risk of death 





To the best of our knowledge, we are the first group to report the association between 
presence or absence of anaemia or haemoglobin levels and incidence of dementia over long-
term follow-up in a large cohort of unselected stroke survivors. Our study results highlight 
the importance of death as the competing risk in development of post-stroke dementia, which 
carries substantial mortality risk after hospital discharge. Whilst we did not demonstrate the 
clear dose–response relationship between anaemia and dementia risk, Kaplan-Meier curves 
demonstrate the potential effect of whether diagnosis of dementia was made after stroke. 
Given that dementia diagnosis is based on progressive nature of clinical assessment criteria, 
this complex nature should be taken into account in risk prediction studies of post-stroke 
dementia.  
 
The key strengths of the study include relatively large sample of unselected  consecutive 
stroke admissions. We were also able to control for acute stroke factors and comprehensive 
list of co-morbidities as well as functional disability.  We were able to follow up for long-
term with minimal loss to follow-up due to NHS record linkage. In UK, almost everyone has 
a NHS number and Office of National Statistics data are linked to local NHS databases and 
vital status including mortality are ascertained regularly.  Local NHS record linkage allows us 
to determine the date of dementia diagnosis appearing in health records and therefore we 
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were able to estimate hazards ratios rather than odds ratio. We were able to robustly 
considered death as competing risk by Fine & Gray methods [14]. 
 
Indeed, numerous risk factors for cognitive decline and dementia have been previously 
reported in stroke survivors. These included age, history of cardio-metabolic disease, atrial 
fibrillation, lower educational attainment, stroke severity, aphasia, recurrent stroke, pre-stroke 
cognitive impairment, and neuroimaging makers such as medial temporal lobe atrophy and 
hippocampal changes [15]. Currently developed are complex [16][17][18] and it is unlikely 
to be of clinical utility. For prediction tools to be of clinical utility, criteria should include 
readily available parameters that can be reliably measured with minimal resources. Discharge 
haemoglobin level offers a potential role given that there are several plausible 
pathophysiological mechanistic links between anaemia and post-stroke dementia. Anaemia 
could lead to chronic reduction of cerebral oxygenation secondary to decreased oxygen-
carrying capacity of the blood. Alternatively, it serves as a marker of diseases and processes 
such as ischemic and lower erythropoietin levels, thereby increasing the risk of neuronal 
degeneration, iron dysregulation and associated with increased brain oxidative stress [19].  
Anaemia could also be associated with the progression of white matter disease [20]. Another 
potential causal pathway is that it could operate through  reduced physical function due to 
tiredness secondary to anaemia. It was proposed that cardiorespiratory fitness is linked to 
executive functions through an increase in brain derived neurotrophin factor or a 
parasympathetic related increase in efficiency of prefrontal neural function [21]. Therefore, 
presence of functional impairment as the results of stroke damage may increase the risk of 




We observe that the significant relationship between anaemia and dementia risk was 
attenuated after controlling for pre-stroke disability assessed using modified Rankin scale and 
other risk factors. This is in agreement with results from an early systematic review on this 
topic [22].  We observe the higher risk of dementia associated with the latter years of the 
study suggesting there may be bias towards under diagnosis of dementia in earlier years of 
this study. Of note, dementia diagnosis has changed over the study period; changing trends in 
diagnosis of dementia in the UK has been reported between 2005 and 2015.  The proportion 
of people diagnosed with dementia in the UK doubled from 0·42% (19,635 of 4,640,290 
participants) in 2005 to 0·82% (25,925 of 3,159,754 participants) in 2015 (χ² test for trend, 
p<0·0001) [23]. 
 
There are some limitations. As a registry based observational study we were not able to fully 
adjust for treatment effects (e.g. blood transfusion, use of iron supplements and 
erythropoietin stimulating agents) after hospital discharge which might have attenuated the 
actual effect size of the relationship between anaemia of low Hb levels and subsequent risk of 
dementia. We were unable to take into account the duration of anaemia or assess the impact 
of abnormal haemoglobin levels after hospital discharge. We did not stratify analysis by 
anaemia subtype as this will reduce the number of outcomes (dementia) further unlikely to 
produce any meaningful results due to loss of power. We also did not control for some 
haematological parameters and biological parameters such as B12, folate levels and kidney 
function which may have confounded the association. As an observational study there may be 
residual confounding as well as effect of known or unknown confounders which were not 
taken into account. As a record linkage study, we were not able to confidently differentiate 
between different types of common dementias, although majority of cases are most likely to 
be either vascular dementia or dementia of mixed pathology. We also relied on dementia 
11 
 
diagnosis made by clinicians in various setting evident by variation in annual diagnosis rates 
but perhaps this reflects the real world nature of the study. This variation may vary with time 
due to increasing awareness and better diagnosis. Due to relatively small sample size coupled 
with potential under-estimation of dementia diagnosis we were not able to examine the 
specific cause of anaemia and risk of dementia.  It is not clear how much of cognitive decline 
after stroke is related to focal damage due to stroke per se, and how much is indeed 
contributed by other risk factors including anaemia. However, the fact anaemia may 
contribute cognitive decline  through stroke (e.g. stroke size due to inadequate collateral 
circulation efficiency) makes it almost implausible to address this issue in human studies. The 
only way perhaps to study this would be inducing anaemia in animal models where a 
comparator group with same stroke type, size, and location would not have anaemia. 
 
 
In summary, while we did not find strong association between anaemia and incident dementia 
in stroke survivors, the study should be replicated in the future with follow-up data 
specifically collected to diagnose dementia in stroke survivors. Future studies should also 
examine the link between specific type of anaemia and dementia risk in patients with stroke. 
With improvement in awareness of dementia after stroke and improvement in diagnosis of 
dementia, it presents an opportunity to revisit the actual risk estimates of previously identified 
risk factors as well as potential new risk factors with the view of developing simple 
prediction rule that is pragmatic and applicable in low resource setting thus useful for daily 
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Figure 1: Kaplan Meier Curves showing the incidence of dementia in patients without 
anaemia (top line) and with anaemia (bottom line) 






Table 1: Sex-specific sample characteristics comparison between stroke patients who were 
anaemic at discharge and those without anaemia  
 No Anaemia Anaemia p-value 
 Total N = 5019 Total N = 2435  
Men  2863 879  
Age (mean/SD) 71.5 (12.2) 78.9 (10.5) <0.001 
Stroke Type    
  Haemorrhagic 340 (11.9%) 66 (7.6%) <0.001 
  Ischaemic 2506 (88.1%) 807 (92.4%)  
OCSP    
  LACS 726 (27.4%) 212 (25.9%) 0.004 
  PACS 937 (35.4%) 331 (40.4%)  
  POCS 556 (21.0%) 136 (16.6%)  
  TACS 325 (12.3%) 94 (11.5%)  
  Undefined 105 (4.0%) 46 (5.6%)  
Pre-stroke mRS    
0 2201 (79.8%) 493 (60.4%) <0.001 
1 275 (10.0%) 124 (15.2%)  
2 126 (4.6%) 78 (9.6%)  
3 97 (3.5%) 85 (10.4%)  
4 46 (1.7%) 26 (3.2%)  
5 13 (0.5%) 10 (1.2%)  
Comorbidities     
Previous stroke/TIA 587 (20.9%) 237 (27.9%)  
CHD including MI 401 (14.0%) 231 (26.3%) <0.001 
PVD 40 (1.4%) 45 (5.1%) <0.001 
COPD (incl. 
Emphysema/bronchitis) 102 (3.6%) 65 (7.4%) <0.001 
CKD 39 (1.4%) 72 (8.2%) <0.001 
Congestive Cardiac 
Failure 125 (4.4%) 100 (11.4%) <0.001 
Atrial Fibrillation 263 (9.2%) 144 (16.4%) <0.001 
Hypertension 615 (21.5%) 345 (39.2%) <0.001 
Hyperlipidemia 104 (3.6%) 69 (7.9%) <0.001 
Diabetes Mellitus 209 (7.3%) 166 (18.9%) <0.001 
Cancers 259 (9.0%) 191 (21.7%) <0.001 
    
Women  2156 1556  
Age (mean/SD) 77.3 (12.1) 80.5 (10.8) <0.001 
Stroke Type    
  Haemorrhagic 262 (12.2%) 127 (8.2%) <0.001 
  Ischaemic 1887 (87.8%) 1424 (91.8%)  
OCSP    
  LACS 581 (28.8%) 379 (26.0%) 0.026 
  PACS 762 (37.7%) 581 (39.9%)  
  POCS 346 (17.1%) 216 (14.8%)  
  TACS 267 (13.2%) 218 (15.0%)  
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  Undefined 64 (3.2%) 63 (4.3%)  
Pre-stroke mRS    
0 1469 (70.8%) 795 (54.6%) <0.001 
1 219 (10.6%) 231 (15.9%)  
2 158 (7.6%) 149 (10.2%)  
3 153 (7.4%) 184 (12.6%)  
4 61 (2.9%) 77 (5.3%)  
5 14 (0.7%) 19 (1.3%)  
Comorbidities     
Previous stroke/TIA 465 (21.9%) 408 (26.9%) <0.001 
CHD including MI 236 (10.9%) 267 (17.2%) <0.001 
PVD 28 (1.3%) 30 (1.9%) 0.13 
COPD (incl. 
Emphysema/bronchitis) 60 (2.8%) 61 (3.9%) 0.054 
CKD 34 (1.6%) 58 (3.7%) <0.001 
Congestive Cardiac 
Failure 113 (5.2%) 143 (9.2%) <0.001 
Atrial Fibrillation 243 (11.3%) 212 (13.6%) 0.031 
Hypertension 603 (28.0%) 538 (34.6%) <0.001 
Hyperlipidemia 71 (3.3%) 72 (4.6%) 0.037 
Diabetes Mellitus 106 (4.9%) 173 (11.1%) <0.001 
Cancers 174 (8.1%) 172 (11.1%) 0.002 






Table 2: Hazard Ratios (95% CI) for dementia incidence post stroke after hospital discharge –anaemia  
Model HR (95% CI) for anaemia HR (95% CI) for 20 g/dL unit 
increase in HB 
HR (95% CI) for anaemia* HR (95% CI) for 20 g/dL 
unit increase in HB* 
 N=578 failures / 7454 N=578 failures / 7454 N=578 failures / 7454 N=578 failures / 7454 
A 1.21 (1.01,1.43) 0.70 (0.64,0.77) 1.34 (1.13,1.58) 1.00 (0.91,1.10) 
B 1.21 (1.01,1.44) 0.88 (0.80,0.97) 1.03 (0.86,1.22) 1.01 (0.92,1.11) 
C 1.17 (0.97,1.40) 0.89 (0.80,0.98) 1.02 (0.85,1.26) 1.02 (0.93,1.13) 
D 1.13 (0.94,1.36) 0.91 (0.82,1.01) 1.00 (0.89,1.22) 1.04 (0.94,1.15) 
E 1.10 (0.91,1.33) 0.93 (0.83,1.03) 0.97 (0.80,1.17) 1.05 (0.95,1.16) 
F 1.10 (0.92,1.33) 0.95 (0.85,1.06) 0.97 (0.80,1.17) 1.05(0.95,1.16) 
*Competing risk model with death as competing risk 
A: age, sex adjusted 
B: age, sex, stroke characteristics adjusted (subtype, OCSP) 
C: age, sex, stroke type, OCSP and pre-stroke mRS adjusted 
D: C + additional adjustments for key risk factors for vascular dementia AF, CHD, previous stroke/TIA, PVD, hypertension 
E: D+ other co-morbidities  





Figure 1: Kaplan Meier Curves showing the incidence of dementia in patients without anaemia (top line) and with anaemia (bottom line)  
 
 N at risk       
No anaemia 5019 2848 1413 755 216 0 




Figure 2: Kaplan-Meier Curve for dementia incidence for individual year  
 
Year (vs. 2003) Hazard Ratios (95% CI) 
2004 1.16 (0.78,1.71) 
2005 1.27 (0.86,1.86) 
2006 1.46 (0.99,2.17) 
2007 1.75 (1.18,2.59) 
2008 1.56 (0.96,2.54) 
2009 1.76 (1.15,2.69) 
2010 1.56 (1.04,2.34) 
2011 1.99 (1.32,2.99) 
2012 2.82 (1.89,4.22) 
2013 2.99 (1.88,4.76) 
2014                   3.24 (2.01,5.2) 
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Supplementary Table 1: Annual incidence of dementia overtime in patients who survived to hospital discharge over 10 years follow up 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
2003 N at risk 469 418 391 353 316 291 263 242 220 207 206 201 
 Incidence/1,000 14.93 4.78 5.12 5.67 12.66 10.31 30.42 12.4 22.73 9.66 19.42 0 
2004 N at risk 538 469 424 385 350 307 281 252 232 218 214 211 
 Incidence/1,000 9.29 19.19 9.43 20.78 2.86 19.54 24.91 7.94 21.55 22.94 9.35 0 
2005 N at risk  528 452 408 377 343 311 288 263 250 245 237 
 Incidence/1,000  9.47 15.49 12.25 13.26 17.49 12.86 27.78 15.21 28 28.57 0 
2006 N at risk   493 427 361 328 304 275 254 239 240 232 
 Incidence/1,000   16.23 30.44 8.31 9.15 23.03 10.91 23.62 4.18 33.33 12.93 
2007 N at risk    490 414 362 326 297 254 232 228 221 
 Incidence/1,000    14.29 31.4 2.76 15.34 40.4 19.69 21.55 30.7 4.52 
2008 N at risk     265 227 194 174 160 146 145 142 
 Incidence/1,000     18.87 22.03 25.77 22.99 6.25 6.85 20.69 14.08 
2009 N at risk      460 398 361 324 309 308 301 
 Incidence/1,000      17.39 30.15 16.62 18.52 9.71 22.73 3.32 
2010 N at risk       692 611 543 508 497 482 
 Incidence/1,000       11.56 18.00 18.42 21.65 20.12 6.22 
2011 N at risk        651 575 540 531 521 
 Incidence/1,000        24.58 20.87 18.52 16.95 11.52 
2012 N at risk         671 587 565 547 
 Incidence/1,000         23.85 34.07 28.32 16.45 
2013 N at risk          487 426 395 
 Incidence/1,000          26.69 44.6 5.06 
2014 N at risk           671 612 
 Incidence/1,000           37.26 13.07 
2015 N at risk            191 
 Incidence/1,000            10.47 
N at risk = total number of patients – Number of deaths occurring within the year  
